| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Svenja Bremshey, Juliana Groß, Kim Renken, Olivia Andrea Massec. The role of serotonin in depression-A historical roundup and future directions. Journal of neurochemistry. 2024-03-13. PMID:38477031. |
we will review the evolution of antidepressant treatments, systemic research on depression over the years, and future research applications that will help to bridge the gap between systemic research and neurotransmitter dynamics using biosensors. |
2024-03-13 |
2024-03-15 |
Not clear |
| Zhen Wang, Hui Xu, Zheng Wang, Hang Zhou, Lijuan Zhang, Yu Wang, Miaoxiu Li, Yunfeng Zho. Effect of tuina on sleep quality, psychological state and neurotransmitter level in patients with insomnia: a systematic review and meta-analysis. Frontiers in neurology. vol 15. 2024-03-07. PMID:38450067. |
numerous studies have shown that tuina can improve the symptoms of sleep disorders in patients with insomnia while relieving anxiety and depression and regulating neurotransmitter levels. |
2024-03-07 |
2024-03-09 |
Not clear |
| Fanhao Meng, Long Wan. Bidirectional mechanism of comorbidity of depression and insomnia based on synaptic plasticity. Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences. vol 48. issue 10. 2024-03-03. PMID:38432881. |
pathological alterations of depression and insomnia may perturb the production and release of neurotransmitter, dendritic spine remodeling and elimination, which converges and reflects in aberrant synaptic dynamics. |
2024-03-03 |
2024-03-06 |
Not clear |
| Yayun Wu, Lijuan Liu, Ya Zhao, Xiong Li, Junhong Hu, Hanlin Li, Ruizhi Zha. Xiaoyaosan promotes neurotransmitter transmission and alleviates CUMS-induced depression by regulating the expression of Oct1 and Oct3 in astrocytes of the prefrontal cortex. Journal of ethnopharmacology. 2024-02-17. PMID:38367929. |
xiaoyaosan promotes neurotransmitter transmission and alleviates cums-induced depression by regulating the expression of oct1 and oct3 in astrocytes of the prefrontal cortex. |
2024-02-17 |
2024-02-20 |
Not clear |
| Xiling Li, Chun Chien, Yifu Han, Zihan Sun, Xun Chen, Dion Dickma. Autocrine inhibition by a glutamate-gated chloride channel mediates presynaptic homeostatic depression. Science advances. vol 7. issue 49. 2024-02-14. PMID:34851664. |
homeostatic modulation of presynaptic neurotransmitter release is a fundamental form of plasticity that stabilizes neural activity, where presynaptic homeostatic depression (phd) can adaptively diminish synaptic strength. |
2024-02-14 |
2024-02-16 |
Not clear |
| Yang Gao, Kexin Nie, Hongzhan Wang, Hui Dong, Yueheng Tan. Research progress on antidepressant effects and mechanisms of berberine. Frontiers in pharmacology. vol 15. 2024-02-06. PMID:38318145. |
this review summarizes the evidence of pharmacological applications of berberine in treating depression and elucidates the mechanisms of berberine regulating neurotransmitter levels, promoting the regeneration of hippocampal neurons, improving hypothalamic-pituitary-adrenal axis dysfunction, anti-oxidative stress, and suppressing inflammatory status in order to provide a reference for further research and clinical application of berberine. |
2024-02-06 |
2024-02-09 |
Not clear |
| Bo Sun, Xuewei Cao, Ming Xin, Ruiqian Gua. Treatment of Depression with Acupuncture Based on Pathophysiological Mechanism. International journal of general medicine. vol 17. 2024-02-05. PMID:38314195. |
acupuncture treatment of depression is an ancient and effective method, the mechanism involves multiple biological pathways, for example, by regulating neurotransmitter levels, regulating the neuroendocrine axis, improving neuroplasticity, anti-inflammatory and other effects, improving emotional state and play an antidepressant role. |
2024-02-05 |
2024-02-07 |
Not clear |
| Kelly E Dunham, B Jill Vento. Electrochemical and biosensor techniques to monitor neurotransmitter changes with depression. Analytical and bioanalytical chemistry. 2024-01-30. PMID:38289354. |
electrochemical and biosensor techniques to monitor neurotransmitter changes with depression. |
2024-01-30 |
2024-02-01 |
Not clear |
| Aditi Vyas, Gaurav Dosh. A Cross Talk on the Role of Contemporary Biomarkers in Depression. Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals. 2024-01-23. PMID:38261718. |
evidence to date demonstrates that markers of inflammatory, neurotransmitter, neurotrophic, neuroendocrine, and metabolic function can predict the psychological and physical consequences of depression in individuals, allowing for the development of new therapeutic targets with fewer side effects. |
2024-01-23 |
2024-01-26 |
Not clear |
| Tingyu Zhao, Ting Liu, Lu Wang, Kaiqiang Xie, Hui Tang, Mimi Tan. Dysfunction of neurotransmitter metabolism is associated with the severity of depression in first-diagnosed, drug-naïve depressed patients. Journal of affective disorders. 2024-01-10. PMID:38199403. |
dysfunction of neurotransmitter metabolism is associated with the severity of depression in first-diagnosed, drug-naïve depressed patients. |
2024-01-10 |
2024-01-13 |
Not clear |
| Sisi Lin, Zhe Zhou, Yiming Qi, Jiabing Chen, Guoshu Xu, Yunfu Shi, Zhihong Yu, Mingqian Li, Kequn Cha. Depression promotes breast cancer progression by regulating amino acid neurotransmitter metabolism and gut microbial disturbance. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 2024-01-09. PMID:38194019. |
depression promotes breast cancer progression by regulating amino acid neurotransmitter metabolism and gut microbial disturbance. |
2024-01-09 |
2024-01-10 |
Not clear |
| Timur Liwinski, Undine E Lang, Annette B Brühl, Else Schneide. Exploring the Therapeutic Potential of Gamma-Aminobutyric Acid in Stress and Depressive Disorders through the Gut-Brain Axis. Biomedicines. vol 11. issue 12. 2023-12-23. PMID:38137351. |
research conducted on individuals with depression reveals that major depressive disorders (mdds) coincide with diminished levels of the inhibitory neurotransmitter γ-aminobutyric acid (gaba) in the brain, as well as modifications in the subunit composition of the primary receptors (gaba |
2023-12-23 |
2023-12-25 |
Not clear |
| Ruhui Shen, Zhipeng Li, Huiyun Wang, Yongchao Wang, Xiaofang Li, Qian Yang, Yingjie Fu, Ming Li, Li-Na Ga. Chinese Materia Medica in Treating Depression: The Role of Intestinal Microenvironment. The American journal of Chinese medicine. 2023-11-06. PMID:37930334. |
in turn, depression affects intestinal microenvironment homeostasis by altering intestinal tissue structure, flora abundance and metabolism, hormone secretion, neurotransmitter transmission, and immune balance. |
2023-11-06 |
2023-11-08 |
Not clear |
| Massimo Fioranelli, Maria Grazia Roccia, Bianca Przybylek, Maria Luisa Gar. The Role of Brain-Derived Neurotrophic Factor (BDNF) in Depression and Cardiovascular Disease: A Systematic Review. Life (Basel, Switzerland). vol 13. issue 10. 2023-10-30. PMID:37895349. |
brain-derived neurotrophic factor (bdnf) has been suggested as a reliable biomarker for depression and a strong predictor of cvd because it plays an important role in neuron survival and growth, serves as a neurotransmitter modulator, and promotes neuronal plasticity. |
2023-10-30 |
2023-11-08 |
Not clear |
| Hamzah Shatri, Purnamandala, Rudy Hidayat, Robert Sinto, Alvina Widhani, Rudi Putranto, Rr Dyah Purnamasari, Eka Ginanjar, Chyntia Olivia Maurine Jasirwa. The correlation of anxiety and depression with C3 and C4 Levels and systemic lupus erythematosus activity. BMC psychiatry. vol 23. issue 1. 2023-10-26. PMID:37884917. |
anxiety and depression can be induced by immunological and neurotransmitter dysregulation, which is characterized by hypothalamic-pituitary-adrenal (hpa) axis dysfunction, production of proinflammatory cytokines, and activation of complement in the blood, such as c3 and c4. |
2023-10-26 |
2023-11-08 |
Not clear |
| Enav Z Zusman, Cecil M Y Chau, Jeffrey N Bone, Kaia Hookenson, Ursula Brain, Melissa B Glier, Ruth E Grunau, Joanne Weinberg, Angela M Devlin, Tim F Oberlande. Prenatal serotonin reuptake inhibitor antidepressant exposure, SLC6A4 genetic variations, and cortisol activity in 6-year-old children of depressed mothers: A cohort study. Developmental psychobiology. vol 65. issue 7. 2023-10-20. PMID:37860904. |
prenatal exposure to maternal depression and serotonin reuptake inhibitor (sri) antidepressants both affect the development of the hypothalamic-pituitary-adrenal (hpa) system, possibly via the neurotransmitter serotonin (5ht). |
2023-10-20 |
2023-11-08 |
Not clear |
| Mengqing Liu, Yi Ling, Yue Zhang, Lulu Liu, Yue Qiu, Yi Liu, Yanyan Yi. The role of EndophilinA1 in chronic unpredicted mild stress-induced depression model mice. International immunopharmacology. vol 124. issue Pt B. 2023-10-14. PMID:37837716. |
it has been reported that epa1 is involved in neurotransmitter release, which indicates that the protein may be involved in depression. |
2023-10-14 |
2023-11-08 |
mouse |
| Yan Wang, Yuzhen Huang, Min Zhao, Lu Yang, Kunhan Su, Hao Wu, Yuting Wang, Qing Chang, Wanli Li. Zuojin pill improves chronic unpredictable stress-induced depression-like behavior and gastrointestinal dysfunction in mice via the theTPH2/5-HT pathway. Phytomedicine : international journal of phytotherapy and phytopharmacology. vol 120. 2023-09-16. PMID:37716030. |
the complex bidirectional communication between the gastrointestinal tract and the brain is associated with mental disorders such as depression; serotonin, as a crucial neurotransmitter in the communication system between the central nervous system and the gastrointestinal tract, has effects on regulating gastrointestinal motility and sensation and improving psychosomatic status. |
2023-09-16 |
2023-10-07 |
mouse |
| Kurt A Jellinge. Depression in dementia with Lewy bodies: a critical update. Journal of neural transmission (Vienna, Austria : 1996). 2023-07-07. PMID:37418037. |
depression in dlb that is frequently underdiagnosed and undertreated, has been related to a variety of pathogenic mechanisms associated with the basic neurodegenerative process, in particular dysfunctions of neurotransmitter systems (decreased monoaminergic/serotonergic, noradrenergic and dopaminergic metabolism), α-synuclein pathology, synaptic zinc dysregulation, proteasome inhibition, gray matter volume loss in prefrontal and temporal areas as well as dysfunction of neuronal circuits with decreased functional connectivity of specific brain networks. |
2023-07-07 |
2023-08-14 |
Not clear |
| Carla Fonseca, Miren Ettcheto, Joana Bicker, Maria José Fernandes, Amílcar Falcão, Antoni Camins, Ana Fortun. Under the umbrella of depression and Alzheimer's disease physiopathology: can cannabinoids be a dual-pleiotropic therapy? Ageing research reviews. 2023-07-06. PMID:37414155. |
besides the well-known imbalance of neurotransmitter levels, including serotonin, noradrenaline, dopamine and glutamate, recent scientific evidence highlights aberrant spine density, neuroinflammation, dysregulation of neurotrophic factor levels and formation of amyloid beta (aβ) peptides, as the main physiopathological mechanisms compromised in depression and ad. |
2023-07-06 |
2023-08-14 |
Not clear |